-
1
-
-
67650924286
-
Review of the Lynch syndrome: History, molecular genetics, screening, differential diagnosis, and medicolegal rami-fcations
-
Lynch HT, Lynch PM, Lanspa SJ, et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal rami-fcations. Clin Genet. 2009;76(1):1-18.
-
(2009)
Clin Genet.
, vol.76
, Issue.1
, pp. 1-18
-
-
Lynch, H.T.1
Lynch, P.M.2
Lanspa, S.J.3
-
2
-
-
0034538160
-
Population carrier frequency of hMSH2 and hMLH1 mutations
-
Dunlop MG, Farrington SM, Nicholl I, et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer. 2000;83(12):1643-1645.
-
(2000)
Br J Cancer.
, vol.83
, Issue.12
, pp. 1643-1645
-
-
Dunlop, M.G.1
Farrington, S.M.2
Nicholl, I.3
-
3
-
-
78650844345
-
The search for unaffected individuals with Lynch syndrome: Do the ends justify the means?
-
Hampel H, de la Chapelle A. The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res (Phila). 2011;4(1):1-5.
-
(2011)
Cancer Prev Res (Phila).
, vol.4
, Issue.1
, pp. 1-5
-
-
Hampel, H.1
De La Chapelle, A.2
-
4
-
-
0027966880
-
A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden
-
Aaltonen LA, Sankila R, Mecklin JP, et al. A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev. 1994;18(1):57-63.
-
(1994)
Cancer Detect Prev.
, vol.18
, Issue.1
, pp. 57-63
-
-
Aaltonen, L.A.1
Sankila, R.2
Mecklin, J.P.3
-
5
-
-
13744255043
-
Application of genetics to the prevention of colorectal cancer. Recent results in cancer research 2005;Fortschritte der Krebsforschung
-
Hopper JL. Application of genetics to the prevention of colorectal cancer. Recent results in cancer research 2005;Fortschritte der Krebsforschung. Pro-gres dans les recherches sur le cancer. 166:17-33.
-
Pro-gres dans les Recherches sur le Cancer.
, vol.166
, pp. 17-33
-
-
Hopper, J.L.1
-
6
-
-
84873942317
-
Cancer risks for MLH1 and MSH2 mutation carriers
-
Dowty JG, Win AK, Buchanan DD, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013;34(3):490-497.
-
(2013)
Hum Mutat.
, vol.34
, Issue.3
, pp. 490-497
-
-
Dowty, J.G.1
Win, A.K.2
Buchanan, D.D.3
-
7
-
-
0034011564
-
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
-
Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118(5):829-834.
-
(2000)
Gastroenterology.
, vol.118
, Issue.5
, pp. 829-834
-
-
Jarvinen, H.J.1
Aarnio, M.2
Mustonen, H.3
-
8
-
-
77951758579
-
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
-
Cairns SR, Scholefeld JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666-689.
-
(2010)
Gut.
, vol.59
, Issue.5
, pp. 666-689
-
-
Cairns, S.R.1
Scholefeld, J.H.2
Steele, R.J.3
-
9
-
-
42949177399
-
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
-
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-160.
-
(2008)
CA Cancer J Clin.
, vol.58
, Issue.3
, pp. 130-160
-
-
Levin, B.1
Lieberman, D.A.2
McFarland, B.3
-
11
-
-
84876900933
-
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): Recommendations by a group of European experts
-
Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62(6):812-823.
-
(2013)
Gut.
, vol.62
, Issue.6
, pp. 812-823
-
-
Vasen, H.F.1
Blanco, I.2
Aktan-Collan, K.3
-
12
-
-
33749067855
-
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review
-
Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: A systematic review. JAMA. 2006;296(12):1507-1517.
-
(2006)
JAMA
, vol.296
, Issue.12
, pp. 1507-1517
-
-
Lindor, N.M.1
Petersen, G.M.2
Hadley, D.W.3
-
13
-
-
37349041679
-
Aspirin dose and duration of use and risk of colorectal cancer in men
-
Chan AT, Giovannucci EL, Meyerhardt JA, et al. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008;134(1):21-28.
-
(2008)
Gastroenterology.
, vol.134
, Issue.1
, pp. 21-28
-
-
Chan, A.T.1
Giovannucci, E.L.2
Meyerhardt, J.A.3
-
14
-
-
65349152488
-
Aspirin and non-steroidal anti-infammatory drugs for cancer prevention: An international consensus statement
-
Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-infammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10(5):501-507.
-
(2009)
Lancet Oncol.
, vol.10
, Issue.5
, pp. 501-507
-
-
Cuzick, J.1
Otto, F.2
Baron, J.A.3
-
15
-
-
34248157118
-
Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies
-
Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet. 2007;369(9573):1603-1613.
-
(2007)
Lancet.
, vol.369
, Issue.9573
, pp. 1603-1613
-
-
Flossmann, E.1
Rothwell, P.M.2
-
16
-
-
78650215449
-
Long-term effect of aspirin on colo-rectal cancer incidence and mortality: 20-year follow-up of fve randomised trials
-
Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colo-rectal cancer incidence and mortality: 20-year follow-up of fve randomised trials. Lancet. 2010;376(9754):1741-1750.
-
(2010)
Lancet.
, vol.376
, Issue.9754
, pp. 1741-1750
-
-
Rothwell, P.M.1
Wilson, M.2
Elwin, C.E.3
-
17
-
-
60749128400
-
Aspirin for the chemoprevention of colo-rectal adenomas: Meta-analysis of the randomized trials
-
Cole BF, Logan RF, Halabi S, et al. Aspirin for the chemoprevention of colo-rectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst. 2009;101(4):256-266.
-
(2009)
J Natl Cancer Inst.
, vol.101
, Issue.4
, pp. 256-266
-
-
Cole, B.F.1
Logan, R.F.2
Halabi, S.3
-
18
-
-
84893158245
-
The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: A randomised trial
-
Ishikawa H, Mutoh M, Suzuki S, et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut. 2014;63(11):1755-1759.
-
(2014)
Gut.
, vol.63
, Issue.11
, pp. 1755-1759
-
-
Ishikawa, H.1
Mutoh, M.2
Suzuki, S.3
-
19
-
-
57749107623
-
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome
-
Burn J, Bishop DT, Mecklin JP, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008;359(24):2567-2578.
-
(2008)
N Engl J Med.
, vol.359
, Issue.24
, pp. 2567-2578
-
-
Burn, J.1
Bishop, D.T.2
Mecklin, J.P.3
-
20
-
-
83955161674
-
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
-
Burn J, Gerdes AM, Macrae F, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378(9809):2081-2087.
-
(2011)
Lancet.
, vol.378
, Issue.9809
, pp. 2081-2087
-
-
Burn, J.1
Gerdes, A.M.2
Macrae, F.3
-
21
-
-
38849170356
-
Colon Cancer Family Registry: An international resource for studies of the genetic epidemiology of colon cancer
-
Newcomb PA, Baron J, Cotterchio M, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2331-2343.
-
(2007)
Cancer Epidemiol Biomarkers Prev.
, vol.16
, Issue.11
, pp. 2331-2343
-
-
Newcomb, P.A.1
Baron, J.2
Cotterchio, M.3
-
22
-
-
78651074177
-
Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases
-
Rumilla K, Schowalter K V, Lindor NM, et al. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn. 2011;13(1):93-99.
-
(2011)
J Mol Diagn.
, vol.13
, Issue.1
, pp. 93-99
-
-
Rumilla, K.1
Schowalter, K.V.2
Lindor, N.M.3
-
23
-
-
26644441586
-
Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer
-
Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23(27):6524-6532.
-
(2005)
J Clin Oncol.
, vol.23
, Issue.27
, pp. 6524-6532
-
-
Southey, M.C.1
Jenkins, M.A.2
Mead, L.3
-
24
-
-
48549099663
-
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
-
Senter L, Clendenning M, Sotamaa K, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135(2):419-428.
-
(2008)
Gastroenterology.
, vol.135
, Issue.2
, pp. 419-428
-
-
Senter, L.1
Clendenning, M.2
Sotamaa, K.3
-
25
-
-
84860605783
-
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
-
Win AK, Young JP, Lindor NM, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012;30(9):958-964.
-
(2012)
J Clin Oncol.
, vol.30
, Issue.9
, pp. 958-964
-
-
Win, A.K.1
Young, J.P.2
Lindor, N.M.3
-
26
-
-
21344437509
-
A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes
-
Antoniou AC, Goldgar DE, Andrieu N, et al. A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol. 2005;29(1):1-11.
-
(2005)
Genet Epidemiol.
, vol.29
, Issue.1
, pp. 1-11
-
-
Antoniou, A.C.1
Goldgar, D.E.2
Andrieu, N.3
-
27
-
-
33746853116
-
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: A report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group
-
Andrieu N, Easton D F, Chang-Claude J, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol. 2006;24(21):3361-3366.
-
(2006)
J Clin Oncol.
, vol.24
, Issue.21
, pp. 3361-3366
-
-
Andrieu, N.1
Easton, D.F.2
Chang-Claude, J.3
-
28
-
-
41649097333
-
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
-
Antoniou AC, Spurdle AB, Sinilnikova OM, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008;82(4):937-948.
-
(2008)
Am J Hum Genet.
, vol.82
, Issue.4
, pp. 937-948
-
-
Antoniou, A.C.1
Spurdle, A.B.2
Sinilnikova, O.M.3
-
29
-
-
79953226290
-
Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers
-
Win AK, Dowty JG, Antill YC, et al. Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol. 2011;117(4):899-905.
-
(2011)
Obstet Gynecol.
, vol.117
, Issue.4
, pp. 899-905
-
-
Win, A.K.1
Dowty, J.G.2
Antill, Y.C.3
-
30
-
-
76749132847
-
Smoking and colorectal cancer in lynch syndrome: Results from the colon cancer family registry and the university of Texas M.D. Anderson cancer center
-
Pande M, Lynch PM, Hopper JL, et al. Smoking and Colorectal Cancer in Lynch Syndrome: Results from the Colon Cancer Family Registry and The University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010;16(4):1331-1339.
-
(2010)
Clin Cancer Res.
, vol.16
, Issue.4
, pp. 1331-1339
-
-
Pande, M.1
Lynch, P.M.2
Hopper, J.L.3
-
31
-
-
0003964363
-
-
American Cancer Society Atlanta: American Cancer Society
-
American Cancer Society. Cancer Facts & Figures 2013. In. Atlanta: American Cancer Society; 2013.
-
(2013)
Cancer Facts & Figures 2013
-
-
-
32
-
-
33645826906
-
Cancer risks for mismatch repair gene mutation carriers: A population-based early onset case-family study
-
Jenkins MA, Baglietto L, Dowty JG, et al. Cancer Risks For Mismatch Repair Gene Mutation Carriers: A Population-Based Early Onset Case-Family Study. Clin Gastroenterol Hepatol. 2006;4(4):489-498.
-
(2006)
Clin Gastroenterol Hepatol.
, vol.4
, Issue.4
, pp. 489-498
-
-
Jenkins, M.A.1
Baglietto, L.2
Dowty, J.G.3
-
33
-
-
70449647008
-
Proportional hazards tests and diagnostics based on weighted residuals
-
Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515-526.
-
(1994)
Biometrika.
, vol.81
, Issue.3
, pp. 515-526
-
-
Grambsch, P.M.1
Therneau, T.M.2
-
35
-
-
0002745670
-
Regression standard errors in clustered samples
-
Rogers W. Regression standard errors in clustered samples. Stata Technical Bulletin. 1999;3:19-23.
-
(1999)
Stata Technical Bulletin.
, vol.3
, pp. 19-23
-
-
Rogers, W.1
-
36
-
-
0033918632
-
A note on robust variance estimation for cluster-correlated data
-
Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645-646.
-
(2000)
Biometrics.
, vol.56
, Issue.2
, pp. 645-646
-
-
Williams, R.L.1
-
37
-
-
80052225995
-
Modifcation of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes
-
Rebbeck TR, Mitra N, Domchek SM, et al. Modifcation of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Res. 2011;71(17):5792-5805.
-
(2011)
Cancer Res.
, vol.71
, Issue.17
, pp. 5792-5805
-
-
Rebbeck, T.R.1
Mitra, N.2
Domchek, S.M.3
-
38
-
-
84874372330
-
Dose-risk and duration-risk relationships between aspirin and colorectal cancer: A meta-analysis of published cohort studies
-
Ye X, Fu J, Yang Y, et al. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One. 2013;8(2):e57578.
-
(2013)
PLoS One.
, vol.8
, Issue.2
, pp. e57578
-
-
Ye, X.1
Fu, J.2
Yang, Y.3
-
39
-
-
0037464808
-
Interaction revisited: The difference between two estimates
-
Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219.
-
(2003)
BMJ
, vol.326
, Issue.7382
, pp. 219
-
-
Altman, D.G.1
Bland, J.M.2
-
40
-
-
79955832527
-
A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis
-
Burn J, Bishop DT, Chapman PD, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila). 2011;4(5):655-665.
-
(2011)
Cancer Prev Res (Phila).
, vol.4
, Issue.5
, pp. 655-665
-
-
Burn, J.1
Bishop, D.T.2
Chapman, P.D.3
-
41
-
-
0027197062
-
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
-
Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328(18):1313-1316.
-
(1993)
N Engl J Med.
, vol.328
, Issue.18
, pp. 1313-1316
-
-
Giardiello, F.M.1
Hamilton, S.R.2
Krush, A.J.3
-
42
-
-
0242486770
-
Rofecoxib reduces polyp recurrence in familial polyposis
-
Hallak A, Alon-Baron L, Shamir R, et al. Rofecoxib reduces polyp recurrence in familial polyposis. Dig Dis Sci. 2003;48(10):1998-2002.
-
(2003)
Dig Dis Sci.
, vol.48
, Issue.10
, pp. 1998-2002
-
-
Hallak, A.1
Alon-Baron, L.2
Shamir, R.3
-
43
-
-
17744418769
-
The effect of celecoxib, a cycloox-ygenase-2 inhibitor, in familial adenomatous polyposis
-
Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cycloox-ygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342(26):1946-1952.
-
(2000)
N Engl J Med.
, vol.342
, Issue.26
, pp. 1946-1952
-
-
Steinbach, G.1
Lynch, P.M.2
Phillips, R.K.3
-
44
-
-
0028850446
-
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-infammatory drug regimen in reversing adenomas exceeding 33 months
-
Winde G, Schmid KW, Schlegel W, et al. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-infammatory drug regimen in reversing adenomas exceeding 33 months. Dis Colon Rectum. 1995;38(8):813-830.
-
(1995)
Dis Colon Rectum.
, vol.38
, Issue.8
, pp. 813-830
-
-
Winde, G.1
Schmid, K.W.2
Schlegel, W.3
-
45
-
-
0029829551
-
Nonsteroidal anti-infam-matory drug use and protection against colorectal cancer in women
-
Reeves MJ, Newcomb PA, Trentham-Dietz A, et al. Nonsteroidal anti-infam-matory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 1996;5(12):955-960.
-
(1996)
Cancer Epidemiol Biomarkers Prev.
, vol.5
, Issue.12
, pp. 955-960
-
-
Reeves, M.J.1
Newcomb, P.A.2
Trentham-Dietz, A.3
-
46
-
-
0023687241
-
Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study
-
Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 1988;48(15):4399-4404.
-
(1988)
Cancer Res.
, vol.48
, Issue.15
, pp. 4399-4404
-
-
Kune, G.A.1
Kune, S.2
Watson, L.F.3
-
47
-
-
0037138743
-
Nonsteroidal anti-infammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
-
Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-infammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94(4):252-266.
-
(2002)
J Natl Cancer Inst.
, vol.94
, Issue.4
, pp. 252-266
-
-
Thun, M.J.1
Henley, S.J.2
Patrono, C.3
-
48
-
-
34249673868
-
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
-
Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med. 2007;356(21):2131-2142.
-
(2007)
N Engl J Med.
, vol.356
, Issue.21
, pp. 2131-2142
-
-
Chan, A.T.1
Ogino, S.2
Fuchs, C.S.3
-
49
-
-
0033615352
-
PPARdelta is an APC-regulated target of nonsteroidal anti-infammatory drugs
-
He TC, Chan TA, Vogelstein B, et al. PPARdelta is an APC-regulated target of nonsteroidal anti-infammatory drugs. Cell. 1999;99(3):335-345.
-
(1999)
Cell.
, vol.99
, Issue.3
, pp. 335-345
-
-
He, T.C.1
Chan, T.A.2
Vogelstein, B.3
-
50
-
-
0028803728
-
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
-
Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995;83(3):493-501.
-
(1995)
Cell.
, vol.83
, Issue.3
, pp. 493-501
-
-
Tsujii, M.1
DuBois, R.N.2
-
51
-
-
0031882916
-
Mechanisms underlying nonsteroi-dal antiinfammatory drug-mediated apoptosis
-
Chan TA, Morin PJ, Vogelstein B, et al. Mechanisms underlying nonsteroi-dal antiinfammatory drug-mediated apoptosis. Proc Natl Acad Sci USA. 1998;95(2):681-686.
-
(1998)
Proc Natl Acad Sci USA.
, vol.95
, Issue.2
, pp. 681-686
-
-
Chan, T.A.1
Morin, P.J.2
Vogelstein, B.3
-
52
-
-
0035951493
-
Cancer research. Anti-infammatories inhibit cancer growth-but how?
-
Marx J. Cancer research. Anti-infammatories inhibit cancer growth-but how? Science. 2001;291(5504):581-582.
-
(2001)
Science.
, vol.291
, Issue.5504
, pp. 581-582
-
-
Marx, J.1
-
53
-
-
78650840096
-
Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}
-
Greenspan EJ, Madigan JP, Boardman LA, et al. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila). 2011;4(1):161-171.
-
(2011)
Cancer Prev Res (Phila).
, vol.4
, Issue.1
, pp. 161-171
-
-
Greenspan, E.J.1
Madigan, J.P.2
Boardman, L.A.3
-
54
-
-
84860291337
-
Does aspirin really reduce the risk of colon cancer?
-
author reply 1587
-
Jankowski J, Barr H, Moayyedi P. Does aspirin really reduce the risk of colon cancer? Lancet. 2012;379(9826):1586-1587; author reply 1587.
-
(2012)
Lancet.
, vol.379
, Issue.9826
, pp. 1586-1587
-
-
Jankowski, J.1
Barr, H.2
Moayyedi, P.3
-
55
-
-
77956830345
-
Diagnosis and management of Barrett's oesophagus
-
Jankowski J, Barr H, Wang K, et al. Diagnosis and management of Barrett's oesophagus. BMJ. 2010;341:c4551.
-
(2010)
BMJ
, vol.341
, pp. c4551
-
-
Jankowski, J.1
Barr, H.2
Wang, K.3
-
56
-
-
0023933549
-
Clinicopathological features of non-steroidal antiinfammatory drug-induced small intestinal strictures
-
Bjarnason I, Price AB, Zanelli G, et al. Clinicopathological features of non-steroidal antiinfammatory drug-induced small intestinal strictures. Gastro-enterology. 1988;94(4):1070-1074.
-
(1988)
Gastro-enterology.
, vol.94
, Issue.4
, pp. 1070-1074
-
-
Bjarnason, I.1
Price, A.B.2
Zanelli, G.3
-
57
-
-
84907754172
-
Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease
-
Ishihara M, Ohmiya N, Nakamura M, et al. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease. Aliment Pharmacol Ther. 2014;40(5):538-547.
-
(2014)
Aliment Pharmacol Ther.
, vol.40
, Issue.5
, pp. 538-547
-
-
Ishihara, M.1
Ohmiya, N.2
Nakamura, M.3
-
58
-
-
0032724388
-
The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption
-
Kaufman DW, Kelly JP, Wiholm BE, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94(11):3189-3196.
-
(1999)
Am J Gastroenterol.
, vol.94
, Issue.11
, pp. 3189-3196
-
-
Kaufman, D.W.1
Kelly, J.P.2
Wiholm, B.E.3
-
59
-
-
84922532328
-
Estimates of benefts and harms of prophylactic use of aspirin in the general population
-
Cuzick J, Thorat MA, Bosetti C, et al. Estimates of benefts and harms of prophylactic use of aspirin in the general population. Ann Oncol. 2014;26(1):47-57.
-
(2014)
Ann Oncol.
, vol.26
, Issue.1
, pp. 47-57
-
-
Cuzick, J.1
Thorat, M.A.2
Bosetti, C.3
-
60
-
-
84922908649
-
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
-
van Kruijsdijk RC, Visseren FL, Ridker PM, et al. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart. 2014;101(5):369-376.
-
(2014)
Heart.
, vol.101
, Issue.5
, pp. 369-376
-
-
Van Kruijsdijk, R.C.1
Visseren, F.L.2
Ridker, P.M.3
|